Callan Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.54M | Sell |
22,223
-3,096
| -12% | -$215K | 0.11% | 87 |
|
|
2024
Q4 | $2.18M | Sell |
25,319
-1,097
| -4% | -$94.4K | 0.16% | 70 |
|
|
2024
Q3 | $3.15M | Buy |
26,416
+1,719
| +7% | +$205K | 0.22% | 63 |
|
|
2024
Q2 | $3.53M | Buy |
24,697
+1,155
| +5% | +$165K | 0.29% | 57 |
|
|
2024
Q1 | $3.02M | Buy |
23,542
+2,283
| +11% | +$293K | 0.27% | 55 |
|
|
2023
Q4 | $2.2M | Buy |
21,259
+15,366
| +261% | +$1.59M | 0.21% | 57 |
|
|
2023
Q3 | $536K | Buy |
5,893
+1,649
| +39% | +$150K | 0.06% | 118 |
|
|
2023
Q2 | $343K | Hold |
4,244
| – | – | 0.04% | 134 |
|
|
2023
Q1 | $338K | Hold |
4,244
| – | – | 0.04% | 135 |
|
|
2022
Q4 | $287K | Buy |
4,244
+200
| +5% | +$13.5K | 0.04% | 149 |
|
|
2022
Q3 | $201K | Hold |
4,044
| – | – | 0.03% | 127 |
|
|
2022
Q2 | $225K | Sell |
4,044
-92
| -2% | -$5.12K | 0.03% | 107 |
|
|
2022
Q1 | $230K | Hold |
4,136
| – | – | 0.03% | 113 |
|
|
2021
Q4 | $232K | Buy |
+4,136
| New | +$232K | 0.03% | 125 |
|